Meet the Speakers of 2018

/Meet the Speakers of 2018
Meet the Speakers of 20182018-02-19T13:06:13+00:00

Plenary Speakers

Philip Nelson

Director of Engineering

Google Research

Paul R. Biondi

Senior Vice President, Head of Business Development

Bristol-Myers Squibb

Francois Maisonrouge

Senior Managing Director

Evercore Partners

Arie S. Belldegrun MD, FACS

Founder Kite Pharma

Executive Chairman & Co-Founder, Allogene Therapeutics

Bruce R. Rosengard, MD

Vice President, External Innovation, Medical Devices

Johnson and Johnson Medical Devices

Speakers

Ami Appelbaum

Chairman

Israel Innovation Authority

Aharon Aharon

CEO

Israel Innovation Authority

Next Generation Oncology Treatments

Phil L’Huillier, PhD, MBA

Head, European Innovation Hub

MSD

Prof. Jeffrey A. Sosman, MD

Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Tal Zaks, MD, PhD

Chief Medical Officer

Moderna Therapeutics

Prof. Dror Harats, MD

Chief Executive Officer

Vascular Biogenics

Prof. David Sidransky, MD

Johns Hopkins School of Medicine and

Israel Biotech Fund, Co-Founder and General Partner

Fighting Rare Genetic Diseases Using Novel Therapeutic Approaches

Daniel Fischer

Founder

Tevard Biosciences

Julia Hawkins

Partner

LocalGlobe

Chris Adams, PhD, MBA

Chief Executive Officer

Cydan II Inc.

Tauhid Ali, PhD

Vice President and Head of TAK-celerator

Takeda

Yael Weiss, MD, PhD

Vice President Business Development

Ultragenyx

Novel Clinical Trial Designs and Technologies to Accelerate Drug Development

Dan Vesely

Co-Founder, CliniCrowd

Partner at Sdemagroup

Marc Funk

COO & President

Lonza Pharma & Biotech

Daphna Laifenfeld, PhD

Chief Strategy Officer

Ibex Medical Analytics

Erhan Bilal, PhD

IBM Research

Computational Biology Center

Iris Grossman, PhD

Chief Scientific Officer

Camp4 Therapeutics:

Nanomedicine and its Role in New Medical Therapeutics

Prof. Ronit Satchi-Fainaro, PhD

Head, Cancer Angiogenesis and Nanomedicine Laboratory

Sackler Faculty of Medicine, Tel Aviv University

Prof. Dina Ben-Yehuda, PhD

Dean

Hadassah-Hebrew University Faculty of Medicine

Anand Subramony, PhD

Vice President, Novel Product Technologies

MedImmune

Prof. Simon Benita, PhD

Head of Nano Delivery Systems

Hebrew University of Jerusalem

From Academic Research to Industry

Seth Salpeter

Co-Founder & CTO

CuResponse

Nadav Peles

Co-Founder, Acting CEO

Ta Geza

Ayala Pollack

Inventor and Medical Director

OphtimedRx

Hila Goldman Aslan

CEO

DiA Imaging Analysis

Itai Kela

Senior Director, Head of Healthcare & Biotechnology

Israel Innovation Authority

Roni Mamluk

CEO

Ayala Pharmaceuticals

Yuval Ofek

Founder & Chairman

DayTwo

Einat Zisman

Former CEO

FutuRx

Daphna Murvitz

Co-Founder and CEO

8400 Health Network

Tomer Behor

CEO

RenewSenses

Eyal Zimlichman

Deputy General Director, Chief Medical Officer and Chief Innovation Officer

Sheba Medical Center Hospital

Aviv Zeevi Balasiano

VP, Head of Division - Technology Infrastructure

Israel Innovation Authority

Prof. Eli Hazum

Head, IDEA program

YEDA

Pasi Sorvisto

Co-Founder and Director

SPARK Finland

Prof. Avigidor Scherz

Weizmann Institute of Science and co-inventor & Scientific Advisor

Steba BioTech

Prof. Moussa B.H. Youdim

Prof. Emeritus at Technion & Founder of numerous startups

President & CSO, Youdim Pharmaceuticals

Prof. Yechezkel “Chezy” Barenholz

Prof. at Hebrew U and Co-founder of numerous startups

Prof. Michel Revel, MD, PhD

Chief Scientist, Kadimastem Ltd

Prof. Emeritus, WIS

Shay Sela

VP, Business Development of Life Sciences

YEDA

Jessica Weiss

CEO

Lydus Medical

Prof. Faud Fares

Founder

CanCuRX Ltd

Yoram Eshel

CEO

On Sight

Yitshak Francis

Scientific Advisor

Qrons

Larry Loev

CEO

Ariel Scientific Innovations (Ariel U)

Netta Cohen

CEO

BGN Technologies

Yaron Daniely

CEO

Yissum

Silvie Luria

CEO

Sheba (Tel HaShomer)

Tamar Raz

CEO

Hadasit

Zeev Zehavi

Vice President of Venture Investments

Johnson & Johnson Innovation - JJDC, Inc. (JJDC)

Michael L. Salgaller, PhD

Supervisor, IDMU

Technology Transfer Center, National Cancer Institute, National Institutes of Health

Prof. David Sidransky, MD

Johns Hopkins School of Medicine and

Israel Biotech Fund, Co-Founder and General Partner

Gil Granot-Mayer

CEO, Yeda R&D - Technology Transfer

Weizmann Institute of Science

Cutting Edge Medical Device Technologies: Metabolic, Ophthalmology

Elo Kent

Head, Global Innovation

Santen

Prof. Moshe Phillip

Director of the Institute for Endocrinology and Diabetes

Israel National Center for Childhood Diabetes

Prof. Ehud Assia

Head, Ophthalmology Department

Prof. Anat Loewenstein MD, MHA

Head, Ophthalmology Division

Tel Aviv Medical Center

Irit Yaniv, MD

General Partner

Accelmed

Barak Azmon, MD

Ophthalmic Entrepreneur

Digital Health, IoT, and Big Data – New Armamentarium in Medicine

Peter H.W. van der Goes, Jr.

Head of Healthcare IT and Digital Health Banking

Goldman Sachs

Prof. Amir Lerman, MD

Division of Cardiovascular Diseases and Internal Medicine

Mayo Clinic, Rochester,

Philip Nelson

Director of Engineering

Google Research

Prof. Shai Shen-Orr

Chief Scientist, CytoReason

Faculty of Medicine, Technion

Ran Shaul

Co-Founder and Chief Product Officer

K Health

Ariel Beery

CEO

MobileODT

Ofer Tzadik

COO & President

TytoCare

Amir Magner

CEO

CyberMDX

Joshua Milner, MD

Chief, Laboratory of Allergic Diseases

National Institute of Health

Ziv Ofek

Founder and CEO

MDClone

John D. Halamka, MD, MS

Chief Information Officer

Beth Israel Deaconess System

Elie Lobel

Chief Executive Officer

Orange Healthcare

Anat Naschitz

Managing Director

Orbimed Advisors

Allen Kamer

Managing Partner

OurCrowd Qure

Personalized Diagnostics and Treatments

David Fenstermacher, PhD

Vice President R&D-Bioinformatics

Medimmune

Randy J. Prebula

Partner

Hogan Lovells, Washington, DC, USA

Miro Venturi, PhD

Global Head - Diagnostics Biomarkers

F. Hoffmann-La Roche Ltd

Shai Rosenberg, MD, PhD

Neuro-Oncology & Head of Cancer Computational Biology Lab.

Hadassah - Hebrew University Medical Center

Prof. Gideon Rechavi, MD, PhD

Head

Sheba Cancer Research Center

Varda Shalev, MD, MPH

Managing Director

Morris Kahn & Maccabi Research & Innovation Institute at Maccabi Health Care Services

Brain Health

Yuval Mor

CEO

Beyond Verbal

Michael C. Irizarry

Vice-President of Early Phase Neurosciences

Eli Lilly

Prof. Michael Hornberger

Head of Department of Medicine & Professor of Applied Dementia Research at the Norwich Medical School

Director of Aging Research in the Norfolk & Suffolk Mental Health Trust

Mark Carlton

CSO

Cerevance Therapeutics

Prof. John Gallacher

Director, Dementia Platform UK

University of Oxford

Prof. Nir Giladi, PhD

Director, Neurology Division

Tel Aviv Sourasky Medical Center

Tetsuyuki Maruyama, PhD

Chief Scientific Officer

Dementia Discovery Fund, SV Life Sciences Managers

Corporate Panel

William Shen

Executive Director, Business Development

Bristol-Myers Squibb

Michal Silverberg

Managing Director

Novartis Venture Fund

Gil Bar-Nahum, PhD

Managing Director

Jefferies International, London, UK

Simon Gisby

Managing Director

Deloitte Corporate Finance LLC

Michael Martin, PhD

Global Head

Takeda Ventures, Inc.

Zeev Zehavi

Vice President of Venture Investments

Johnson & Johnson Innovation - JJDC, Inc. (JJDC)

David Cassak

Managing Partner

Innovation in Medtech